shares
-
Financial
New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan
Disclaimer: SAFE SA (the “Company”) has arranged financing in the form of convertible bonds into new or existing shares (OCEANE)…
Read More » -
Financial
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
BURLINGTON, Mass., August 2, 2024–(BUSINESS WIRE)–Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic…
Read More » -
Financial
Bone Biologics Announces Pricing of $2.0 Million Public Offering
BURLINGTON, Mass., March 4, 2024–(BUSINESS WIRE)–Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic…
Read More » -
Financial
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
MELVILEE, N.Y., Feb. 06, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (NASDAQ: BRTX), a clinical stage…
Read More » -
Financial
Spineway-Shares reverse split
Reverse split by exchange of 2,000 existing shares for 1 new share Start of share split period: January 25, 2024 Effective…
Read More » -
Financial
Stryker declares a $0.80 per share quarterly dividend
Kalamazoo, Michigan, Dec. 05, 2023 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly…
Read More » -
Financial
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BURLINGTON, Mass., November 20, 2023–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today…
Read More » -
Financial
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
BURLINGTON, Mass., November 17, 2023–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today…
Read More » -
Financial
Early Warning Report – Acquisition of Aurora Spine Corporation Shares
Toronto, Ontario, Oct. 27, 2023 (GLOBE NEWSWIRE) — David Rosenkrantz (“Acquiror”) announces that he has filed an early warning report…
Read More » -
Financial
Vicarious Surgical Announces Launch of Proposed Public Offering
WALTHAM, Mass., August 2, 2023–(BUSINESS WIRE)–Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics…
Read More » -
Biologics
BioRestorative Therapies Announces $2.1 Million Registered Direct Offering
MELVILLE, N.Y., July 11, 2023 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical stage…
Read More » -
Financial
Xtant Medical Announces Closing of $15 Million Private Placement
BELGRADE, Mont., July 07, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Xtant Medical Announces $15 Million Private Placement
BELGRADE, Mont., July 03, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Financial
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash
Combination creates a leading personalized 3D-printed orthopedic medical device company DURHAM, N.C. and BILLERICA, Mass., June 23, 2023 (GLOBE NEWSWIRE)…
Read More » -
Financial
Bone Biologics Prices $5.0 Million Underwritten Public Offering
BURLINGTON, Mass., June 15, 2023–(BUSINESS WIRE)– Bone Biologics Corporation (NASDAQ: BBLG) (“Bone Biologics” or the “Company”), a developer of orthobiologic products…
Read More »